Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Eagle Pharmaceuticals stock | $52.29

Learn how to easily invest in Eagle Pharmaceuticals stock.

Eagle Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Eagle Pharmaceuticals shares (EGRX) are listed on the NASDAQ and all prices are listed in US Dollars. Eagle Pharmaceuticals employs 106 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Eagle Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EGRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Eagle Pharmaceuticals stock price (NASDAQ: EGRX)

Use our graph to track the performance of EGRX stocks over time.

Eagle Pharmaceuticals shares at a glance

Information last updated 2021-10-23.
Latest market close$52.29
52-week range$36.48 - $58.25
50-day moving average $53.59
200-day moving average $46.41
Wall St. target price$48.50
PE ratio 38.7908
Dividend yield N/A (0%)
Earnings per share (TTM) $1.35

Buy Eagle Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Eagle Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Eagle Pharmaceuticals price performance over time

Historical closes compared with the close of $52.29 from 2021-10-22

1 week (2021-10-18) -1.25%
1 month (2021-09-24) -3.36%
3 months (2021-07-23) 9.30%
6 months (2021-04-23) 18.73%
1 year (2020-10-23) 11.68%
2 years (2019-10-25) -18.02%
3 years (2018-10-25) 57.33
5 years (2016-10-25) 64.52

Is Eagle Pharmaceuticals under- or over-valued?

Valuing Eagle Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Eagle Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Eagle Pharmaceuticals's P/E ratio

Eagle Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Eagle Pharmaceuticals shares trade at around 39x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Eagle Pharmaceuticals's PEG ratio

Eagle Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.91. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Eagle Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Eagle Pharmaceuticals's EBITDA

Eagle Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $33.3 million.

The EBITDA is a measure of a Eagle Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Eagle Pharmaceuticals financials

Revenue TTM $189.2 million
Operating margin TTM 15.73%
Gross profit TTM $142.3 million
Return on assets TTM 7.14%
Return on equity TTM 9.67%
Profit margin 9.68%
Book value $14.88
Market capitalisation $684.8 million

TTM: trailing 12 months

Shorting Eagle Pharmaceuticals shares

There are currently 790,712 Eagle Pharmaceuticals shares held short by investors – that's known as Eagle Pharmaceuticals's "short interest". This figure is 4.8% down from 830,527 last month.

There are a few different ways that this level of interest in shorting Eagle Pharmaceuticals shares can be evaluated.

Eagle Pharmaceuticals's "short interest ratio" (SIR)

Eagle Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Eagle Pharmaceuticals shares currently shorted divided by the average quantity of Eagle Pharmaceuticals shares traded daily (recently around 118725.52552553). Eagle Pharmaceuticals's SIR currently stands at 6.66. In other words for every 100,000 Eagle Pharmaceuticals shares traded daily on the market, roughly 6660 shares are currently held short.

However Eagle Pharmaceuticals's short interest can also be evaluated against the total number of Eagle Pharmaceuticals shares, or, against the total number of tradable Eagle Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eagle Pharmaceuticals's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Eagle Pharmaceuticals shares in existence, roughly 60 shares are currently held short) or 0.1007% of the tradable shares (for every 100,000 tradable Eagle Pharmaceuticals shares, roughly 101 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Eagle Pharmaceuticals.

Find out more about how you can short Eagle Pharmaceuticals stock.

Eagle Pharmaceuticals share dividends

We're not expecting Eagle Pharmaceuticals to pay a dividend over the next 12 months.

Eagle Pharmaceuticals share price volatility

Over the last 12 months, Eagle Pharmaceuticals's shares have ranged in value from as little as $36.48 up to $58.25. A popular way to gauge a stock's volatility is its "beta".

EGRX.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eagle Pharmaceuticals's is 0.7825. This would suggest that Eagle Pharmaceuticals's shares are less volatile than average (for this exchange).

Eagle Pharmaceuticals overview

Eagle Pharmaceuticals, Inc. , a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also includes EP-4104, a dantrolene sodium for exertional heat stroke, as well as to treat organophosphate exposure; EP-5101 (PEMFEXY) for lung cancer and mesothelioma; EGL-5385-C-1701 (fulvestrant) for breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has a strategic collaboration with Tyme Technologies, Inc. to advance oral SM-88 for the treatment of patients with cancer. Eagle Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Eagle Pharmaceuticals is owned by insiders or institutions?
Currently 12.603% of Eagle Pharmaceuticals shares are held by insiders and 94.919% by institutions.
How many people work for Eagle Pharmaceuticals?
Latest data suggests 106 work at Eagle Pharmaceuticals.
When does the fiscal year end for Eagle Pharmaceuticals?
Eagle Pharmaceuticals's fiscal year ends in December.
Where is Eagle Pharmaceuticals based?
Eagle Pharmaceuticals's address is: 50 Tice Boulevard, Woodcliff Lake, NJ, United States, 07677
What is Eagle Pharmaceuticals's ISIN number?
Eagle Pharmaceuticals's international securities identification number is: US2697961082
What is Eagle Pharmaceuticals's CUSIP number?
Eagle Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 269796108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site